70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. - Wikidata - awgldk - TriplyDB

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

http://www.wikidata.org/entity/Q34538363

about

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women Recent advances in the medical treatment of breast cancer Implementing Genome-Driven Oncology.Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer Multigene expression profile testing in breast cancer: is there a role for family physicians?An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.A breast cancer gene signature for indolent disease.Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer.Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.Epidemiology and survival outcome of breast cancer in a nationwide study.A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis.Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers.Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: a guide for upcoming studies and implementations.Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Clinical utility of gene-expression signatures in early stage breast cancer.Research needs in breast cancer.Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer.How the future of clinical cancer diagnostics can contribute to overcoming race-associated cancer disparities.Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.Clinical Trials in the Genomic Era.Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.

P2860

Q28066709-051F2B53-A4A0-48E6-8365-5A17161710FE Q28077637-E5F96C44-62DB-49F9-BE8A-A3412F52B080 Q28078951-99F90220-837F-47E6-B81E-A6C29C699909 Q30235979-D7B8AD75-B3FC-4219-AFD8-3F42B2FD232E Q30313653-23CFB179-AA4D-4224-8859-C2773BD65253 Q33591245-8F2C0FC8-B125-4B23-B239-275197D68573 Q33611126-F4AC2A90-92AF-4A6C-B429-56EAD89FA63F Q33660598-4FF25C82-3000-491F-897E-F86CB59731F3 Q33731278-39679AA4-E69D-4AFC-A9CF-B4017C50E549 Q33756398-3CEFC744-1FEE-417D-9313-C2085D09219D Q33834198-E8C14683-B305-4670-82B9-0BE01D8559CA Q33843780-D0F481C9-8B7E-46CB-B8F8-CBBC6D8943B3 Q33861323-E54852C7-65F1-454B-853A-062E01BA80EA Q33897072-2530FE0E-F2E9-4C93-AD39-7520C5B54186 Q36379148-E8147371-940E-4274-8CA2-390253CD148A Q37496576-CF3F40B5-AFBC-41FA-8E31-D984CA071894 Q37583778-2927D93F-A5D4-4700-BD0B-185AFA27350C Q37639271-65BE52BA-6725-401A-B79A-3044EAC9D892 Q37686041-39156F2A-A5F5-4D44-B13A-90009C7C4848 Q37691100-2783B120-1386-4A4A-8ABF-83CFF87F253E Q37725545-43A72871-DAF7-4542-8058-6A01B04F00D5 Q38374561-A5E69EB6-41A3-41B2-AD74-BB414E0A5976 Q38374747-6BF56AB8-8CE5-447C-82B5-59508BBA4CC5 Q38399507-5F11EEFB-8860-49D5-92D9-30C673B3CFEF Q38606464-080BED13-7F5F-4869-9418-38BFAEBAB52B Q38606467-259456ED-80ED-41F7-ADC3-F605D3F71367 Q38613552-4A45F44C-545D-40CE-847A-9796618448AE Q38686476-91B2CB22-0AD2-4173-BC64-2F1814346658 Q38690101-F28689AD-8811-4361-B3A9-884E18ABD14B Q38696564-C4E99ACD-A2DC-42A0-890F-43E17DD857A6 Q38730837-42C23DC6-CCE3-4918-A652-DF32BF655E1B Q38740539-E112DF49-FDC8-4F0C-A5FB-24396E83AD00 Q38745404-6B2EB79D-A860-480A-8CDE-C5D8EDC44989 Q38754717-7A59ABF2-9C0B-4A26-9FB7-2AC0F8AB53FF Q38796787-E17ED434-A9AE-4963-8F30-83FA12226A31 Q38798405-B545E12E-3881-48E2-86DC-234E1CEDC7B9 Q38803048-7BE9CC4C-18E9-4F16-A9B8-0F95C4F5AEE2 Q38837312-E5C0C993-E7F0-4AF3-889A-7A2F9AFCABA8 Q38905607-D389FA81-56C2-4BC0-839F-6C01EFB87A4C Q39045171-6CEC3909-B939-455B-96EE-C5FF53856E68

P2860

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

http://www.wikidata.org/entity/Q34538363

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@ast

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@en

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@nl

type

label

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@ast

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@en

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@nl

prefLabel

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@ast

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@en

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@nl

P1433

Q34538363-8BD36A87-CCD4-4308-B07F-B172E64E1485

P1476

Q34538363-DD8F5AF7-5708-454D-ADAB-A56A58F41383

P2093

Q34538363-046CA699-016A-46C4-B59E-6C25B601EBE1

Q34538363-04DFD968-15FC-4656-98BC-A5B44A13905B

Q34538363-0C24B5ED-850C-4BC3-90F7-05058AA8DDD0

Q34538363-1382CA37-259F-4B15-8660-60D23D823A36

Q34538363-34ED3746-3E75-4511-9402-8A0050040831

Q34538363-35F2D639-394D-453F-92C5-3CDC96B10089

Q34538363-378C8BAF-ED2B-40EB-BD23-42282DCCEB3E

Q34538363-3A3F06BF-788A-4E80-B690-07E5E64C2AF8

Q34538363-4107A566-77DD-49F0-B52B-CB10849C1427

Q34538363-44D0A383-0A92-4397-9CBD-6B98EB66D2DE

P304

Q34538363-6DF38258-4AE2-4FEA-A3FE-10B63356F319

P31

Q34538363-BD54110A-3A70-47E6-86B7-24E95C0788A1

P356

Q34538363-63974FFF-7201-4401-940E-71046D833A05

P407

Q34538363-748ACC1B-EA86-4B5C-A96B-43D77FAC4D72

P433

Q34538363-2DF45A1A-D314-4D50-88CA-6CBC3EF7464D

P478

Q34538363-F82584FB-1FC4-4809-9F6B-5940698994AE

P50

Q34538363-0FB67386-F532-4150-9326-9D02E18D8F0A

Q34538363-28096EE5-82CA-4794-B8CC-95425AF225E5

Q34538363-4D1B9C77-09FC-473E-9F5A-685E645D948E

P577

Q34538363-0626081E-78FA-477E-B1BD-169B367D8A1E

P698

Q34538363-9D22E11A-AE14-4E62-9FDB-DDB3C1F58885

P356

P1433

The New England Journal of Medicine

P1476

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

@en

P2093

Alastair M Thompson

http://www.w3.org/2001/XMLSchema#string

Annuska M Glas

http://www.w3.org/2001/XMLSchema#string

Bart Meulemans

http://www.w3.org/2001/XMLSchema#string

Carolyn Straehle

http://www.w3.org/2001/XMLSchema#string

Christos Sotiriou

http://www.w3.org/2001/XMLSchema#string

Emiel Rutgers

http://www.w3.org/2001/XMLSchema#string

Erika Matos

http://www.w3.org/2001/XMLSchema#string

Etienne Brain

http://www.w3.org/2001/XMLSchema#string

Fatima Cardoso

http://www.w3.org/2001/XMLSchema#string

Geraldine Thomas

http://www.w3.org/2001/XMLSchema#string

P304

717-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1602253

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

Suzette Delaloge

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27557300

http://www.w3.org/2001/XMLSchema#string